Pathophysiology of Bronchiectasis.
Journal
Seminars in respiratory and critical care medicine
ISSN: 1098-9048
Titre abrégé: Semin Respir Crit Care Med
Pays: United States
ID NLM: 9431858
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
entrez:
14
7
2021
pubmed:
15
7
2021
medline:
24
2
2022
Statut:
ppublish
Résumé
Bronchiectasis is a complex, heterogeneous disorder defined by both a radiological abnormality of permanent bronchial dilatation and a clinical syndrome. There are multiple underlying causes including severe infections, mycobacterial disease, autoimmune conditions, hypersensitivity disorders, and genetic conditions. The pathophysiology of disease is understood in terms of interdependent concepts of chronic infection, inflammation, impaired mucociliary clearance, and structural lung damage. Neutrophilic inflammation is characteristic of the disease, with elevated levels of harmful proteases such as neutrophil elastase associated with worse outcomes. Recent data show that neutrophil extracellular trap formation may be the key mechanism leading to protease release and severe bronchiectasis. Despite the dominant of neutrophilic disease, eosinophilic subtypes are recognized and may require specific treatments. Neutrophilic inflammation is associated with elevated bacterial loads and chronic infection with organisms such as
Identifiants
pubmed: 34261175
doi: 10.1055/s-0041-1730891
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
499-512Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
None declared.